21 November 2024
Misinformation about Bovaer® in the UK
Newsroom
Our latest updates on nutrition, health, and beauty
Our latest statements
Corporate & Financial news
-
-
15 November 2024
DSM-Firmenich AG sold the majority of its stake in Robertet S.A.
-
14 November 2024
DSM-Firmenich AG to sell part of its stake in Robertet S.A.
-
8 November 2024
Fueling our growth with pioneering science
-
31 October 2024
dsm-firmenich Q3 2024 trading update
-
30 October 2024
dsm-firmenich presents ‘Imagine: The Future of Fragrances in the Middle East’ at Beauty World 2024
-
24 October 2024
dsm-firmenich receives validation from the Science Based Targets initiative for its 2045 net-zero targets
-
21 October 2024
dsm-firmenich participates in Beauty World Dubai 2024
-
2 October 2024
dsm-firmenich completes the sale of yeast extract business to Lesaffre
-
1 October 2024
dsm-firmenich completes the sale of its MEG-3® fish oil business to KD Pharma Group SA
-
17 September 2024
dsm-firmenich launches new company website
-
29 August 2024
dsm-firmenich Welcomes Nicole Mancini as Fine Fragrance Principal Perfumer
-
8 August 2024
dsm-firmenich concludes new €1.8 billion Revolving Credit Facility
-
30 July 2024
dsm-firmenich reports H1 2024 results
-
18 July 2024
dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group
-
28 June 2024
Where science meets scent and momentum
-
26 June 2024
dsm-firmenich issues €800 million long-term bond
-
26 June 2024
dsm-firmenich to launch groundbreaking new sports nutrition solutions in collaboration with Team dsm-firmenich PostNL
-
20 June 2024
We are dream catchers
-
18 June 2024
dsm-firmenich gains momentum showcasing the best in ingredients innovation and fragrance experience
-
14 June 2024
DSM shareholders can voluntarily transfer their shares to dsm-firmenich before July 2, 2024, 17:45 hours CEST
-
12 June 2024
dsm-firmenich announces sale of yeast extract business to Lesaffre
-
7 June 2024
Redefining beauty in a diverse world
-
3 June 2024
dsm-firmenich takes strategic actions to strengthen its position as a leading creation and innovation partner in Nutrition, Health and Beauty
-
31 May 2024
dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform
-
30 May 2024
dsm-firmenich dual head office Maastricht inaugurated by Queen Maxima of the Netherlands
-
29 May 2024
Methane-reducing feed ingredient Bovaer® ready for US market launch
-
29 May 2024
dsm-firmenich commits to a strategic partnership with The Colors
-
21 May 2024
Celebrating diversity and disability inclusion in the fragrance industry
-
17 May 2024
dsm-firmenich presents Mind Nose + Matter™ 2024 - “Momentum”
-
8 May 2024
Why bacteria can be good for babies
-
8 May 2024
dsm-firmenich and Lallemand Health Solutions unite to launch synergistic synbiotic solutions
-
7 May 2024
dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024
-
7 May 2024
Share repurchase program to cover share plans completed
-
2 May 2024
dsm-firmenich Q1 2024 trading update
-
30 April 2024
dsm-firmenich's progress on share repurchase program to cover share plans
-
23 April 2024
Unlocking the value of sustainability in animal protein value chains with Sustell™
-
16 April 2024
dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans
-
16 April 2024
dsm-firmenich Partners with ExoLab Italia to Pioneer Plant-Derived Exosome Technology in Personal Care Market
-
8 April 2024
dsm-firmenich announces repurchase of 1.5m shares to cover share plans
-
1 April 2024
Fighting malaria with the power of perfumery
-
27 March 2024
dsm-firmenich donates DSM Art Collection to the municipality of Heerlen
-
19 March 2024
dsm-firmenich partners with Interstellar Lab, leading the way in naturals innovation for Perfumery & Beauty
-
18 March 2024
dsm-firmenich opens state-of-the-art facility in Plainsboro NJ, to scale up innovations in F&B
-
14 March 2024
Increasing production capacity for perfumery ingredients in Europe
-
8 March 2024
dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China
-
29 February 2024
dsm-firmenich publishes 2023 Integrated Annual Report
-
15 February 2024
dsm-firmenich reports 2023 full year results
-
14 February 2024
dsm-firmenich to separate out Animal Nutrition & Health business from the Group
-
12 February 2024
dsm-firmenich completes voluntary cash offer for DSM shares
-
21 November 2024
DSM-Firmenich AG sold all of its stake in Robertet S.A.
-
15 November 2024
DSM-Firmenich AG sold the majority of its stake in Robertet S.A.
-
14 November 2024
DSM-Firmenich AG to sell part of its stake in Robertet S.A.
-
31 October 2024
dsm-firmenich Q3 2024 trading update
-
24 October 2024
dsm-firmenich receives validation from the Science Based Targets initiative for its 2045 net-zero targets
-
2 October 2024
dsm-firmenich completes the sale of yeast extract business to Lesaffre
-
1 October 2024
dsm-firmenich completes the sale of its MEG-3® fish oil business to KD Pharma Group SA
-
8 August 2024
dsm-firmenich concludes new €1.8 billion Revolving Credit Facility
-
30 July 2024
dsm-firmenich reports H1 2024 results
-
18 July 2024
dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group
-
26 June 2024
dsm-firmenich issues €800 million long-term bond
-
14 June 2024
DSM shareholders can voluntarily transfer their shares to dsm-firmenich before July 2, 2024, 17:45 hours CEST
-
12 June 2024
dsm-firmenich announces sale of yeast extract business to Lesaffre
-
3 June 2024
dsm-firmenich takes strategic actions to strengthen its position as a leading creation and innovation partner in Nutrition, Health and Beauty
-
31 May 2024
dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform
-
29 May 2024
Methane-reducing feed ingredient Bovaer® ready for US market launch
-
7 May 2024
dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024
-
7 May 2024
Share repurchase program to cover share plans completed
-
2 May 2024
dsm-firmenich Q1 2024 trading update
-
30 April 2024
dsm-firmenich's progress on share repurchase program to cover share plans
-
16 April 2024
dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans
-
8 April 2024
dsm-firmenich announces repurchase of 1.5m shares to cover share plans
-
8 March 2024
dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China
-
29 February 2024
dsm-firmenich publishes 2023 Integrated Annual Report
-
15 February 2024
dsm-firmenich reports 2023 full year results
-
14 February 2024
dsm-firmenich to separate out Animal Nutrition & Health business from the Group
-
12 February 2024
dsm-firmenich completes voluntary cash offer for DSM shares
-
8 January 2024
dsm-firmenich makes voluntary cash offer for DSM shares
-
31 October 2023
dsm-firmenich reports Q3 2023 results
-
10 October 2023
dsm-firmenich achieves regulatory clearance in China for two HMO ingredients for early life nutrition
-
4 October 2023
dsm-firmenich provides additional pro forma financial information for 2022 and 2023
-
2 August 2023
dsm-firmenich reports H1 2023 results
-
3 July 2023
dsm-firmenich completes acquisition of postbiotics pioneer Adare Biome
-
29 June 2023
dsm-firmenich announces results of extraordinary general meeting of shareholders
-
28 June 2023
Trading update and acceleration of strategic actions
-
22 May 2023
Emmanuel Butstraen appointed as President of Perfumery & Beauty at dsm-firmenich
-
17 May 2023
dsm-firmenich names Katharina Stenholm as Chief Sustainability Officer
-
9 May 2023
dsm-firmenich launches as innovators in nutrition, health, and beauty
-
9 May 2023
Completion of contribution of Firmenich shares
-
4 May 2023
dsm-firmenich announces evolution of CEO structure per 1 September, following completion of the merger
-
2 May 2023
DSM provides Q1 2023 trading update
-
1 May 2023
Final results of the exchange offer: 96.1% of DSM ordinary shares tendered
-
18 April 2023
dsm-firmenich first day of trading on Euronext Amsterdam
-
8 November 2024
Fueling our growth with pioneering science
-
28 June 2024
Where science meets scent and momentum
-
20 June 2024
We are dream catchers
-
7 June 2024
Redefining beauty in a diverse world
-
21 May 2024
Celebrating diversity and disability inclusion in the fragrance industry
-
8 May 2024
Why bacteria can be good for babies
-
23 April 2024
Unlocking the value of sustainability in animal protein value chains with Sustell™
-
1 April 2024
Fighting malaria with the power of perfumery
-
27 March 2024
dsm-firmenich donates DSM Art Collection to the municipality of Heerlen
-
19 March 2024
dsm-firmenich partners with Interstellar Lab, leading the way in naturals innovation for Perfumery & Beauty
-
18 March 2024
dsm-firmenich opens state-of-the-art facility in Plainsboro NJ, to scale up innovations in F&B
-
14 March 2024
Increasing production capacity for perfumery ingredients in Europe
-
24 January 2024
Avansya, a 50/50 joint venture between dsm-firmenich and Cargill received positive safety opinions from European Food Safety Authority and UK Food Standards Agency on it’s product EverSweet® stevia sweetener
-
8 January 2024
dsm-firmenich appoints five new Principal Perfumers
-
8 December 2023
dsm-firmenich reveals fragrance and flavor inspired by PANTONE® Color of the Year
-
6 December 2023
dsm-firmenich inaugurates Kaiseraugst Headquarters and Science & Research Hub
-
1 November 2023
dsm-firmenich breaks ground of new Taste, Texture and Health headquarters and application facility in the Netherlands
-
26 October 2023
dsm-firmenich increases the production capacity of its iconic perfume ingredient Habanolide® with a brand-new facility in Europe
-
16 October 2023
Bringing progress to life for aquatic food systems
-
4 September 2023
Trials confirm efficacy of a methane-reducing feed supplement for ruminants in achieving reductions in methane emissions by dairy cows
-
18 August 2023
Exploring the Future of Sustainable Food with dsm-firmenich at the Lowlands Festival in the Netherlands
-
22 May 2023
Bel makes milk low-methane, working across its entire Slovakian dairy chain with partner dsm-firmenich
-
30 October 2024
dsm-firmenich presents ‘Imagine: The Future of Fragrances in the Middle East’ at Beauty World 2024
-
21 October 2024
dsm-firmenich participates in Beauty World Dubai 2024
-
17 September 2024
dsm-firmenich launches new company website
-
29 August 2024
dsm-firmenich Welcomes Nicole Mancini as Fine Fragrance Principal Perfumer
-
26 June 2024
dsm-firmenich to launch groundbreaking new sports nutrition solutions in collaboration with Team dsm-firmenich PostNL
-
18 June 2024
dsm-firmenich gains momentum showcasing the best in ingredients innovation and fragrance experience
-
30 May 2024
dsm-firmenich dual head office Maastricht inaugurated by Queen Maxima of the Netherlands
-
29 May 2024
dsm-firmenich commits to a strategic partnership with The Colors
-
17 May 2024
dsm-firmenich presents Mind Nose + Matter™ 2024 - “Momentum”
-
8 May 2024
dsm-firmenich and Lallemand Health Solutions unite to launch synergistic synbiotic solutions
-
16 April 2024
dsm-firmenich Partners with ExoLab Italia to Pioneer Plant-Derived Exosome Technology in Personal Care Market
dsm-firmenich reports Q3 2024 trading update
dsm-firmenich announced its Q3 2024 trading update on October 31st.
News from our businesses
Perfumery & Beauty
Taste, Texture & Health
Human, Nutrition & Health
Animal Nutrition & Health
You can learn more about all the news, publications and latest develpments from Animal Nutrution & Health business and stay updated.
Media downloads
On our media library, you can find images and videos related to our executive committee, the opening of our new headquarters in Maastricht and more.
Stay up to date
Be the first to know about key financial results, and corporate news as we continue shaping the future and bringing progress to life.
News Archive
On May 9th, 2023, DSM and Firmenich merged and became one company. You can access the archive of publications by DSM & Firmenich before their merger here.
Quick links
Discover share price information, dividends, and other investor related information.
dsm-firmenich held its Capital Markets Day on June 3 in Paris.
Discover latest results and publications from dsm-firmenich.
Explore more
-
Our Company
Discover how we bring progress to life through purpose-led science, sustainable solutions, building on our 150-year heritage, and leading by example.
-
Executive Committee
The Executive Committee is organized and led by our CEO, who is responsible for overseeing the operational management of the Group.
-
Our businesses
Four complementary businesses, all powered by purpose, people, and pioneering science. A winning formula across nutrition, health, and beauty.